The results proved that FOXQ1 expression was positively correlated with the stromal and immune score in breast invasive carcinoma, prostate adenocarcinoma, thyroid carcinoma, lung adenocarcinoma, and ovarian serous cystadenocarcinoma. This evidence concerns the gene FOXQ1 and ovarian serous cystadenocarcinoma.